January 10, 2022
MIMETAS opens Phenotypic Screening Center
Leiden, May 27, 2021 - MIMETAS, the global leader in human-relevant organ-on-a-chip models, has just…
January 10, 2022
Are we witnessing the dawn of post-theory science? | Artificial intelligence (AI) | The Guardian
Isaac Newton apocryphally discovered his second law – the one about gravity – after an…
January 10, 2022
Hibiscus BioVentures Partners with the Barbara Ann Karmanos Cancer Institute to Advance Translational Cancer Research
- Partnership aims to drive innovation and clinical development of novel therapeutics for cancer treatment…
January 7, 2022
NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
GAITHERSBURG, Md., Jan. 05, 2022 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…
January 7, 2022
REGENXBIO Announces FDA Clearance of IND for Clinical Trial of RGX-202, a Novel Gene Therapy Candidate for Duchenne Muscular Dystrophy
ROCKVILLE, Md., Jan. 6, 2022 /PRNewswire/ -- Potential one-time gene therapy for the treatment of…
January 5, 2022
Zalgen Labs’ move to Frederick is another sign of the BioHealth Capital Region’s strengths
Maryland biotech company Zalgen Labs has moved to Frederick, illustrating the magnetism of the biotech hub for…
